Advanced Search
Library
Poster
Full Title

Chronic Cigarette Mainstream Smoke Exposure Increases Plaque Size in the Brachiocephalic Artery in Apolipoprotein E-Deficient Mice on Chow and Milk-Fat-Enriched Diets


Authored by  S Lebrun, W Stinn, H Weiler, P Kuhl*, K Von Holt, T Wallerath, R Schleef*

Presented at Society of Toxicology (SOT) 2006     
* This author is not affiliated with PMI.
No abstract available. 
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.